Page 3 - Idorsia Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Idorsia issues invitation to the 2024 Annual General Meeting of Shareholders

Idorsia issues invitation to the 2024 Annual General Meeting of Shareholders
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSwitzerland generalSchweizerisches handelsamtsblattAndrewc weissMesse baselGovernance compensation committeeArticles of associationSwiss exchangeApproval of executive committeeCongress centerIdorsia ltdHead of investor relations corporate communicationsIdorsia pharmaceuticals ltdAnnual general meetingAnnual reportSwiss official gazette

Idorsia Pharmaceuticals Ltd: Idorsia issues invitation to the 2024 Annual General Meeting of Shareholders

Allschwil, Switzerland - May 23, 2024Idorsia Ltd (SIX: IDIA) today issued the invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The meeting to

Switzerland generalUnited statesAndrewc weissSchweizerisches handelsamtsblattMesse baselCongress centerSwiss exchangeIdorsia pharmaceuticals ltdIdorsia ltdGovernance compensation committeeHead of investor relations corporate communicationsArticles of associationApproval of executive committeeAnnual general meetingAnnual reportSwiss official gazette

newratings de

newratings de
newratings.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newratings.de Daily Mail and Mail on Sunday newspapers.

United statesSwitzerland generalIhre freundeAndrewc weissSchweizerisches handelsamtsblattArticles of associationHead of investor relations corporate communicationsSwiss exchangeIdorsia pharmaceuticals ltdCongress centerApproval of executive committeeIdorsia ltdGeneral meetingAnnual reportSwiss official gazetteBusiness report

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesThomas clozelIdorsia ltdDiscovery developmentSwiss exchangeDriven oncologyImmunology pipelineIn licenses best class assetOwkin chief medical officerNorth america

Idorsia Ltd Reports Earnings Results for the Full Year Ended December 31, 2023

Idorsia Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was CHF 152.39 million compared to CHF 97.1 million a year ago. Net.

Idorsia ltd